Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ERYTHRYX THERAPEUTICS LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-04-06 to 2022-10-28
Current total value of award: $522337.35
Description: PHASE II  - MOUSE TRIALS MILESTONES 5-9